InsiderTrades

Form 4 for VRTX Vertex Pharmaceuticals

Accepted 2022-02-14 00:00:00 ET · period of report 2022-02-10 · accession 0001209191-22-009232 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
2022-02-14 2022-02-10 VRTX ALTSHULER DAVID EVP, CSO, Gbl Research F - Tax $237.74 -3,518 62.2K -5% -$836.4K
M 2022-02-14 2022-02-11 VRTX ALTSHULER DAVID EVP, CSO, Gbl Research S - Sale $235.02 -2,297 59.9K -4% -$539.8K

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2022-02-10 F D 3,518 $237.74 62,179 D — —
2 Common Common Stock 2022-02-11 S D 841 $233.92 61,338 D — — (F2) Open market sales reported on this line occurred at a weighted average price of $233.92 (range $233.36 to $234.30). (F3) Dr. Altshuler undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.
3 Common Common Stock 2022-02-11 S D 757 $234.95 60,581 D — — (F3) Dr. Altshuler undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. (F4) Open market sales reported on this line occurred at a weighted average price of $234.95 (range $234.47 to $235.28).
4 Common Common Stock 2022-02-11 S D 601 $236.28 59,980 D — — (F5) Open market sales reported on this line occurred at a weighted average price of $236.28 (range $235.84 to $236.74). (F3) Dr. Altshuler undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.
5 Common Common Stock 2022-02-11 S D 98 $237.23 59,882 D — —